Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology-Reference-Cited by-同舟云学术

Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Published:2020-06 Issue:6 Volume:18 Page:755-781
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Hoppe Richard T.¹,Advani Ranjana H.¹,Ai Weiyun Z.²,Ambinder Richard F.³,Armand Philippe⁴,Bello Celeste M.⁵,Benitez Cecil M.¹,Bierman Philip J.⁶,Boughan Kirsten M.⁷,Dabaja Bouthaina⁸,Gordon Leo I.⁹,Hernandez-Ilizaliturri Francisco J.¹⁰,Herrera Alex F.¹¹,Hochberg Ephraim P.¹²,Huang Jiayi¹³,Johnston Patrick B.¹⁴,Kaminski Mark S.¹⁵,Kenkre Vaishalee P.¹⁶,Khan Nadia¹⁷,Lynch Ryan C.¹⁸,Maddocks Kami¹⁹,McConathy Jonathan²⁰,McKinney Matthew²¹,Metzger Monika²²,Morgan David²³,Mulroney Carolyn²⁴,Rabinovitch Rachel²⁵,Rosenspire Karen C.²⁶,Seropian Stuart²⁷,Tao Randa²⁸,Winter Jane N.⁹,Yahalom Joachim²⁹,Burns Jennifer L.³⁰,Ogba Ndiya³⁰

Affiliation:

1. 1Stanford Cancer Institute;

2. 2UCSF Helen Diller Family Comprehensive Cancer Center;

3. 3The Sidney Kimmel Comprehensive Cancer Center at John Hopkins;

4. 4Dana-Farber/Brigham and Women’s Cancer Center;

5. 5Moffitt Cancer Center;

6. 6Fred & Pamela Buffett Cancer Center;

7. 7Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

8. 8The University of Texas MD Anderson Cancer Center;

9. 9Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

10. 10Roswell Park Comprehensive Cancer Center;

11. 11City of Hope National Medical Center;

12. 12Massachusetts General Hospital Cancer Center;

13. 13Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

14. 14Mayo Clinic Cancer Center;

15. 15University of Michigan Rogel Cancer Center;

16. 16University of Wisconsin Carbone Cancer Center;

17. 17Fox Chase Cancer Center;

18. 18Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

19. 19The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

20. 20O'Neal Comprehensive Cancer Center at UAB;

21. 21Duke Cancer Institute;

22. 22St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center;

23. 23Vanderbilt-Ingram Cancer Center;

24. 24UC San Diego Moores Cancer Center;

25. 25University of Colorado Cancer Center;

26. 26Abramson Cancer Center at the University of Pennsylvania;

27. 27Yale Cancer Center/Smilow Cancer Hospital;

28. 28Huntsman Cancer Institute at the University of Utah;

29. 29Memorial Sloan Kettering Cancer Center; and

30. 30National Comprehensive Cancer Network.

Abstract

The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN panel meets at least annually to review comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. Current management of classic HL involves initial treatment with chemotherapy alone or combined modality therapy followed by restaging with PET/CT to assess treatment response. Overall, the introduction of less toxic and more effective regimens has significantly advanced HL cure rates. This portion of the NCCN Guidelines focuses on the management of classic HL.

Publisher

Harborside Press, LLC

Subject

Oncology

Link

https://jnccn.org/downloadpdf/journals/jnccn/18/6/article-p755.xml

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A single-armed proof-of-concept study of Lymfit: A personalized, virtual exercise intervention to improve health outcomes in lymphoma survivors in the pandemic;PLOS ONE;2024-01-05

2. Clinical relevance and therapeutic implications of CD20 expression in Hodgkin's lymphoma;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

3. Estimated impact of ECHELON-1 overall survival on productivity costs in stage III/IV classical Hodgkin lymphoma in the United States;Journal of Managed Care & Specialty Pharmacy;2023-12

4. Appropriate timing to perform an interim 18F-FDG PET/CT in patients with nasal-type extranodal natural killer/T cell lymphoma;Annals of Hematology;2023-11-30

5. A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters;Annals of Hematology;2023-11-15